Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods.
We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes.
Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Oxford Centre For Innovation, New Road,united Kingdom
- Phone
- 441865261471
- co****@****ign.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.oxforddrugdesign.com/
- Keywords
- oncology therapeutics, anti-cancer drugs, tRNA synthetases, small molecules, drug design, drug discovery, virtual screening, ligand optimisation, lead optimisation, Histidine kinases, machine learning.
- HQ
- Oxford
Oxford Drug Design Questions
Oxford Drug Design's helpline number is 441865261471
Oxford Drug Design's website is http://www.oxforddrugdesign.com/
Oxford Drug Design's LinkedIn profile is https://uk.linkedin.com/company/oxforddrugdesign
Oxford Drug Design has
11 employees.
View email and phone details for 11
employees at Oxford Drug Design.
Oxford Drug Design's industry is
Biotechnology Research
Oxford Drug Design's top competitors are
Benevolentai,
Bioversys Ag,
Drug Design Methodologies,
Dept. Of Drug Design And Pharmacology (Ilf), University Of Copenhagen,
Q-Ctrl,
Visual Meaning,
Bicycle Therapeutics,
Inhibox,
Drug By Design,
Optellum.
Oxford Drug Design's support email address is contactus@oxforddrugdesign.com
Oxford Drug Design's categories are Biotechnology Research
Oxford Drug Design's founding year is 2017
